| 摘要 |
This invention relates to compounds of Formula 1 which are pharmacologically useful for the treatment of cancer through sensitization of multi-drug resistant cancer cells to chemotherapeutic agents. (see fig.I) wherein R1, R2, R3, and R4 are, for example, alkyl, aryl, etc., which are defined more specifically hereinafter.
|
